Skip to main content
. 2024 Feb 26;19(2):e0297948. doi: 10.1371/journal.pone.0297948

Table 3. Medication tolerability, discontinuations, adherence over the 8-week study period.

Variable Gabapentin Naltrexone Placebo
Medication tolerability Mean (SD) 91.0 (26.3) 90.8 (25.0) 100.0 (0.0)
Median (IQR) 100.0 (100.0, 100.0) 100.0 (100.0, 100.0) 100.0 (100.0, 100.0)
Permanent treatment discontinuations N (%) 4 (26.7%) 3 (20.0%) 0 (0.0%)
Adherence (VAS Score of 0–100) Mean (SD) 74.4 (40.4) 81.5 (32.9) 96.6 (4.9)
Median (IQR) 99.8 (18.0, 100.0) 99.1 (75.0, 100.0) 99.2 (93.3, 100.0)